Ways And Means’ Legislative Priorities In Health: Medicare Structural Reform, SGR Repeal
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Kevin Brady, new chairman of the House panel’s Health Subcommittee, says he will move ahead with a premium support system for Medicare, an approach to reform favored by PhRMA. Savings generated by that change will offset the cost of repealing the sustainable growth rate formula for Medicare physician payments.
You may also be interested in...
Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
For PhRMA, supporting a move toward privatizing Medicare is a tactic that may help avoid the establishment of new price controls in the system, like the often-discussed mandated drug rebates in Part D.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.